top of page

Search Results

Results found for "GPCR Drug Design"

  • Join the Dr. GPCR Affiliate Program - Empower the GPCR Community with Dr. GPCR Ecosystem Services

    GPCR Affiliate Program and earn commissions by helping connect the global GPCR community. Share our ecosystem, courses, and events to advance drug discovery together. Dr. GPCR community. The Ecosystem is designed for all GPCR professionals to have an affordable and highly effective way to GPCR Ecosystem?

  • University | Dr. GPCR Ecosystem

    Whether you're just starting out or 20 years in — this is your place University is designed for GPCR Explore the Masterclass On Demand Watch Now How Signaling Kinetics Shapes GPCR Drug Action Sam Hoare At Dr.GPCR University, you’ll find: Courses: Dive deep into curated educational content designed by experts GPCR University Masterclasses designed for? Some classes may require basic knowledge of GPCRs, but many are designed to accommodate beginners as

  • Dr. Daniel Wacker | Dr. GPCR Ecosystem

    and in vitro drug discovery. Icahn School of Medicine at Mount Sinai in NYC, where I have been working on structure-function and drug discovery of GPCRs and transporters. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Dr. JoAnn Trejo | Dr. GPCR Ecosystem

    PARs are GPCRs that are activated through an atypical irreversible proteolytic mechanism. biology and for the identification of drug targets and future drug development. which has important functions in hemostasis, thrombosis, inflammation, and cancer and is an important drug GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Dr. Yamina Berchiche | Dr. GPCR Ecosystem

    GPCR podcast , your host and founder, Dr. GPCR Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well , grow, and thrive together to accelerate GPCR drug discovery and improve human health. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Dr. AurĂ©lien Rizk | Dr. GPCR Ecosystem

    Aurélien Rizk is a scientist and entrepreneur in drug discovery. Before focusing on the development of innovative mathematical modeling and simulation methods for drug Interdisciplinary Teamwork and Drug Development Yamina Berchiche and Aurelien Rizk emphasized the significance of interdisciplinary teamwork in drug and technology development, noting the challenges of communication Aurelien Rizk confirmed his attendance at the upcoming GPCR-Targeted Drug Discovery Summit in Boston.

  • GPCR location matters with Dr. Gabriele Kockelkoren | Dr. GPCR Ecosystem

    << Back to podcast list Strategic Partner(s) GPCR location matters with Dr. In my PhD, I studied the nanoscale spatial organization of G protein-coupled receptors (GPCRs) at the revealed heterogeneous spatial patterns of receptor density and activation, that are modulated in a drug-dependent GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Visualizing GLP-1 & GIP Receptors in Islets and Brain | Dr. GPCR Ecosystem

    drug discovery . circuits — insights that inform next-generation functional assay development and translational therapeutic design Why this matters How receptor distribution in islets and brain circuits shapes incretin hormone drug collaborative chemistry enabled in designing receptor-targeted fluorescent ligands The moment when structural GPCR Podcast? Leave a Review.

  • When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem

    His journey highlights the transition from general drug development to a deep dive into G protein-coupled Allosteric Modulation: The New Frontier of GPCR Drug Discovery Ben reflects on the emerging potential “The goal is to smash all the amazing biology together and make a drug.” understand how and where these compounds interact with the receptor, paving the way for structure-based drug design .

  • Donate to Dr GPCR — Support the GPCR Community & University

    Join us in strengthening the global GPCR community. Dr GPCR is a 501(c)(3) non-profit. 501(c)(3) Non-Profit Help Us Build a Global Home for GPCR Science GPCR Ecosystem open, reliable, and thriving. GPCR University Premium to a colleague, mentee, or even yourself — the gift of cutting-edge GPCR education more effective drugs for everyone.

  • Chris Tate: Thermostabilizing GPCRs for Structural Biology | Dr. GPCR Ecosystem

    architecture - what a dimer with no prior blueprint looks like What remains unsolved: why drug discovery Drug discovery's real bottleneck is not structural Tate is direct about where the field now stands: accumulating GPCR structures is no longer the limiting step in drug discovery. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Terry HĂ©bert | Dr. GPCR Ecosystem

    Key Insights from the Conversation Challenge trials don't work without a reliable drug. Dr. His position is that the drug problem has to be solved, or at least bounded, before the vaccine trial design can responsibly change. 90 vaccine candidates is a number about effort, not probability. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem

    Additionally, they have a library of target GPCR heteromers for Oncology. Dr. Cardarelli is a drug development leader with extensive experience driving drug discovery teams in bringing She has extensive experience working with Biologics, and Antibody Drug Conjugates as well as experience GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem

    agonism - a first-in-kind finding at wild-type FFA2 and its implications for biased ligand campaign design unexplored opportunity in existing drug pipelines Antibody therapeutics for GPCRs - the pipeline case The aha moment was not the result itself but recognizing what it meant for how you could design the campaign Almost no company with an approved GPCR-targeting drug has gone back to look at what common receptor It was not the experiment she had designed.

  • Maria Waldhoer: Pharmacological Fingerprints and the Limits of Bias | Dr. GPCR Ecosystem

    dismissal is partly methodological and partly personal: the proudest moment of her scientific life was designing Nordisk, and into biotech at InterAx — where the next challenge is using functional fingerprints to design InterAx treats GPCR pharmacology the way engineers treat aircraft design: build the mathematical model Her most formative scientific moment was designing a compound in HEK293 cells from a hypothesis at Novo design 21:48 — Comorbidities, aging, and the multi-receptor frontier 24:07 — "What endogenous level

  • Dr. Prasenjit Saha | Dr. GPCR Ecosystem

    Traditional drug discovery efforts have focused on agonists and antagonists that bind to the orthosteric ubiquitous class of plasma membrane receptors and serve as targets for more than one-third of all prescribed drugs GPCR Upcoming Live Expert Sessions âžš đź”’Explore the Full Masterclass âžš Unlock the Full Dr. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem

    signaling as a kinetic and time-dependent phenomenon NanoBRET and the evolution of live-cell assay design Receptors in Complexes Behave Differently Than Receptors in Isolation Standard drug screens present a receptors, scaffold proteins, and cytoskeletal elements - and those interactions alter its conformation and drug-binding Understanding receptor complexes is where the next layer of selectivity and specificity in drug discovery unsustainable and what to do instead 22:21 What a PhD actually trains you for 25:42 NanoBRET, live-cell assay design

  • You never know where your GPCR takes you with Dr. Brian Hudson | Dr. GPCR Ecosystem

    << Back to podcast list Strategic Partner(s) You never know where your GPCR takes you with Dr. He has more than 20 years of experience in GPCR, primarily focused on drug discovery and developing new leads a research group that is focused on understanding the pharmacology and function of a group a GPCRs GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem

    His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and the understanding and application of allosteric modulation. - Arthur will work on designing ligands design principles. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem

    From her early doubts to designing preclinical models of fentanyl and xylazine overdose, she reflects pharmacologist—led her to investigate how these drugs shut down breathing in different ways. Who Should Listen This episode is especially relevant for: GPCR drug discovery scientists Respiratory GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem

    pharmacology and drug design. Drug discovery needs modulators more than it needs hammers Arey's philosophy of drug discovery is grounded for a therapeutic strategy built around modulators that can be combined, rather than single agents designed He continues to pioneer in drug discovery studying GPCRs and other target classes. GPCR Podcast? Leave a Review.

  • Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem

    GPCR Podcast, chemical biologist Dr. drug discovery . He explains what chemical design can solve that antibodies can’t, how to validate functional assay systems Why this matters How a chemist with zero biology training became a leader in GPCR probe design. GPCR Podcast? Leave a Review.

  • Univeristy Lecturers Details | Dr. GPCR Ecosystem

    Learn about course content, instructors, and how to advance your expertise in drug discovery. GPCR University Dr. Our flexible course formats are designed to fit your time, depth, and teaching goals — whether you’re GPCR University Instructor and help move GPCR science forward. Aside from his vast experience in drug development, not to mention his extensive publication record,

  • Dr. Pierre Eftekhari | Dr. GPCR Ecosystem

    Pierre Eftekhari "Clinical physiologist and biologist , with more than 25 years of experience in drug I have participated and initiated methodologies for development of pharmacologically active anti-GPCR GPCR Upcoming Live Expert Sessions âžš đź”’Explore the Full Masterclass âžš Unlock the Full Dr. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Arun Shukla: How Two Arrestins Regulate 800 GPCRs | Dr. GPCR Ecosystem

    structural stabilization and live-cell conformational reporting The limits and promise of biased agonism in drug effect, physiological examples of the beta-arrestin-biased receptors pharmacologists have been trying to design The neat bifurcation between G-protein and beta-arrestin signaling that drove early opioid receptor drug design has not held up cleanly in subsequent studies. Shukla's lab designed antibody fragments to stabilize GPCR–beta-arrestin complexes for structural studies

  • Robert Laprairie | Dr. GPCR Ecosystem

    Robert Laprairie is an Associate Professor and the Saskatchewan Research Chair in Drug Discovery and GPCR Ecosystem Upcoming Live Expert Sessions âžš đź”’Explore the Full Masterclass âžš Unlock the Full Dr. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem

    from the endoplasmic reticulum, to the experimental frameworks that made biased agonism a credible drug mutants, and biosensor platforms that helped establish functional selectivity and biased agonism as drug to our understanding of this major class of drug targets. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Dr. Christel Menet | Dr. GPCR Ecosystem

    was the 6th employee and today we are more than 60 :) I have fun every day, and I love working with GPCRs Christel Menet on the web Hyphen Projects GPCRS Drug Discovery Confo Therapeutics LinkedIn Dr. GPCR Ecosystem Upcoming Live Expert Sessions âžš đź”’Explore the Full Masterclass âžš Unlock the Full Dr. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Murat Tunaboylu & Ben Holland | Dr. GPCR Ecosystem

    His current focus is to realise Antiverse’s mission: engineering the future of drug discovery." Murat Tunaboylu on the web Antiverse DSV Future of Drug Discovery Podcast Twist Bioscience LinkedIn Twitter GPCR Upcoming Live Expert Sessions ➚ 🔒Explore the Full Masterclass ➚ Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

  • Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem

    Gilman textbook of pharmacology and is writing its next chapter on angiotensin signaling and angiotensin drugs pneumocytes, beta-2 receptors, and the asthma parallel The ethics of acting on conviction — off-label drug gas pedals and brakes" frame — a lens that has quietly shaped how he reads both disease mechanism and drug GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

bottom of page